PPAR Medicines and Human Disease: The ABCs of It All

Por Apostoli, Anthony J., Nicol, Christopher J. B.
Publicado em 2012

The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination

Por Skelhorne-Gross, Graham, Nicol, Christopher J. B.
Publicado em 2012

Pharmacological and Toxicological Advances in PPAR-Related Medicines

Por Kamijo, Yuji, Nicol, Christopher J., Alexson, Stefan E. H.
Publicado em 2012

Toll-Like Receptor 4 Mutant and Null Mice Retain Morphine-Induced Tolerance, Hyperalgesia, and Physical Dependence

Por Mattioli, Theresa Alexandra, Leduc-Pessah, Heather, Skelhorne-Gross, Graham, Nicol, Christopher J. B., Milne, Brian, Trang, Tuan, Cahill, Catherine M.
Publicado em 2014

Peroxisome proliferator-activated receptor α is involved in the regulation of lipid metabolism by ginseng

Por Yoon, Michung, Lee, Hyunghee, Jeong, Sunhyo, Kim, Jung-Jae, Nicol, Christopher J, Nam, Kung Woo, Kim, Moonza, Cho, Byung Goo, Oh, Goo Taeg
Publicado em 2003

Conditional Disruption of the Peroxisome Proliferator-Activated Receptor γ Gene in Mice Results in Lowered Expression of ABCA1, ABCG1, and apoE in Macrophages and Reduced Cholester...

Por Akiyama, Taro E., Sakai, Shuichi, Lambert, Gilles, Nicol, Christopher J., Matsusue, Kimihiko, Pimprale, Satish, Lee, Ying-Hue, Ricote, Mercedes, Glass, Christopher K., Brewer, H. Bryan, Gonzalez, Frank J.
Publicado em 2002